Search Results

The timing of the last dose of GLP-1 agonist like Ozempic can influence anesthesia-related complications

Use of GLP-1 Receptor Agonists for Weight Loss Leads to Shortages for Diabetes Patients

Researchers say detailed studies are needed to determine whether diabetes drugs themselves or patients’ underlying health explain the observed eye-event risk

Researchers have found that with increasing popularity of GLP-1 drugs, their consumption has significantly increased among those with no FDA approved indications

New paper highlights the need for integrated digital behavioral support, proposing a “habit window hypothesis” and associated research agenda to maximize the long-term success of GLP-1 therapies

The study will begin enrolling eligible patients in September. Thirty participants, ages 12 and older, will be randomized to receive either a placebo or the GLP-1 receptor agonist semaglutide